2',3'-dideoxy-3'-fluoro-5-ethyngluridine
US5157114A · kind A · utility
4Cited by
6References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 17, 1989 |
| Grant date | Oct 20, 1992 |
| Priority date | — |
| Expiry date | Aug 17, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a 3'-substituted pyrimidine nucleoside and its use in medical therapy, particularly in the treatment of HIV infections. Also provided are pharmaceutical formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.